In the fiscal year 2021, Astellas Pharma held assets worth approximately 2.33 trillion Japanese yen, indicating that the previous fiscal year with its total assets of 2.27 trillion yen was only a momentary setback on a general upward trend. The main areas of the Japanese pharmaceutical company include urology, immunology, cardiology, and infectious diseases.
Total assets of Astellas Pharma Inc. from fiscal year 2012 to 2021 (in trillion Japanese yen)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Statistics on Pharmaceutical industry in Scandinavia
Pharmaceutical sales
8
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2021
- Basic Statistic Value of pharmaceutical sales in Norway 2008-2021
- Basic Statistic Value of pharmaceutical sales in Sweden 2000-2021
- Basic Statistic Sales of pharmaceuticals in Norway 2020-2021, by prescription type
- Basic Statistic Revenue of pharmaceuticals in Sweden by type 2021
- Basic Statistic Revenue of most dispensed drugs at pharmacies in Denmark 2021
- Basic Statistic Revenue of pharmaceuticals in Norway by drug category 2020
- Basic Statistic Largest pharmaceutical classes in Sweden 2021, by sales value
Patents and clinical trials
6
- Basic Statistic Number of applications for clinical trials in Denmark 2013-2021, by sponsor
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021, by type of actor
- Premium Statistic Number of applications for clinical trials in Sweden 2014-2021, by sponsor
- Basic Statistic Number of biotechnology patents in Denmark 2011-2019
- Basic Statistic Number of biotechnology patents in Norway 2011-2019
- Basic Statistic Number of biotechnology patents in Sweden 2011-2019
Trade
5
- Basic Statistic Export value of medicinal and pharmaceutical products in Denmark 2010-2021
- Basic Statistic Import and export value of basic pharmaceutical products in Norway 2009-2021
- Basic Statistic Net export value of pharmaceuticals from Sweden 2012-2021
- Basic Statistic Import value of pharmaceuticals into Sweden 2012-2021
- Basic Statistic Export value of pharmaceuticals from Sweden 2012-2021
Key players
6
Further related statistics
18
- Total assets of the Ipsen group 2014-2019
- Total assets of China Resources Sanjiu 2012-2020
- Astellas Pharma's female employee rate FY 2014-2017
- Astellas Pharma's female manager rate FY 2014-2017
- Fuji Pharma's R&D costs FY 2013-2021
- Astellas Pharma's R&D expenditure FY 2012-2021
- Astellas Pharma's operating profit FY 2012-2021
- Astellas Pharma's employee numbers FY 2014-2021
- Astellas Pharma's revenue FY 2021, by region
- Astellas Pharma's net profit FY 2012-2021
- Worldwide generic pharmaceutical M&As count from 2007 to 2015
- Top global generic pharmaceutical companies 2015, by revenue
- Worldwide generic pharmaceutical M&A deal value 2007-2015
- Net profits of leading pharmaceutical companies
- Chile: top pharma companies in 2018, by index score
- Express Scripts' total assets 2006-2017
- Profit margin of top global pharmaceutical companies 2013
- Medco Health Solutions' total assets 2006-2011
Further Content: You might find this interesting as well
Statistics
- Total assets of the Ipsen group 2014-2019
- Total assets of China Resources Sanjiu 2012-2020
- Astellas Pharma's female employee rate FY 2014-2017
- Astellas Pharma's female manager rate FY 2014-2017
- Fuji Pharma's R&D costs FY 2013-2021
- Astellas Pharma's R&D expenditure FY 2012-2021
- Astellas Pharma's operating profit FY 2012-2021
- Astellas Pharma's employee numbers FY 2014-2021
- Astellas Pharma's revenue FY 2021, by region
- Astellas Pharma's net profit FY 2012-2021
- Worldwide generic pharmaceutical M&As count from 2007 to 2015
- Top global generic pharmaceutical companies 2015, by revenue
- Worldwide generic pharmaceutical M&A deal value 2007-2015
- Net profits of leading pharmaceutical companies
- Chile: top pharma companies in 2018, by index score
- Express Scripts' total assets 2006-2017
- Profit margin of top global pharmaceutical companies 2013
- Medco Health Solutions' total assets 2006-2011
Astellas. (April 27, 2022). Total assets of Astellas Pharma Inc. from fiscal year 2012 to 2021 (in trillion Japanese yen) [Graph]. In Statista. Retrieved March 30, 2023, from https://www.statista.com/statistics/825702/astellas-pharma-total-assets/
Astellas. "Total assets of Astellas Pharma Inc. from fiscal year 2012 to 2021 (in trillion Japanese yen)." Chart. April 27, 2022. Statista. Accessed March 30, 2023. https://www.statista.com/statistics/825702/astellas-pharma-total-assets/
Astellas. (2022). Total assets of Astellas Pharma Inc. from fiscal year 2012 to 2021 (in trillion Japanese yen). Statista. Statista Inc.. Accessed: March 30, 2023. https://www.statista.com/statistics/825702/astellas-pharma-total-assets/
Astellas. "Total Assets of Astellas Pharma Inc. from Fiscal Year 2012 to 2021 (in Trillion Japanese Yen)." Statista, Statista Inc., 27 Apr 2022, https://www.statista.com/statistics/825702/astellas-pharma-total-assets/
Astellas, Total assets of Astellas Pharma Inc. from fiscal year 2012 to 2021 (in trillion Japanese yen) Statista, https://www.statista.com/statistics/825702/astellas-pharma-total-assets/ (last visited March 30, 2023)
Total assets of Astellas Pharma Inc. from fiscal year 2012 to 2021 (in trillion Japanese yen) [Graph], Astellas, April 27, 2022. [Online]. Available: https://www.statista.com/statistics/825702/astellas-pharma-total-assets/